Early access to Black Friday 2026: sign up now.
Eurolabs Peptides
Peptides
Peptides · Section06
  • 01Weight managementMetabolic research
  • 02RecoveryTissue and recovery research
  • 03SkinSkin research
  • 04Ageing researchCellular processes
  • 05CognitionNeuroscience
  • 06Growth hormoneHormone research
All products
Science
Science · Section04
  • 01Amino acidsPrinciples and methods
  • 02Peptide bondPrinciples and methods
  • 03SynthesisPrinciples and methods
  • 04AnalysisPrinciples and methods
Study dossier
Applications
Applications · Section06
  • 01Cosmetic & SkincareSix research areas
  • 02Wound Care & RegenerationSix research areas
  • 03Wellness & Sports PerformanceSix research areas
  • 04Metabolic & Pharma-AdjacentSix research areas
  • 05CNS & NootropicsSix research areas
  • 06Longevity & SenolyticsSix research areas
Partners
Partners · Section04
  • 01Affiliate programProgramme and access
  • 02B2BProgramme and access
  • 03ApplyProgramme and access
  • 04Log inProgramme and access
Partners
Study journal
Study journal · Section01
  • 01Study journalPeer-reviewed study database
Study journal
Black Friday
Partners
Product enquiry

How can we help?

We can help with questions about products, strengths, available documents and existing orders.

How can we help?
How can we help?
Customer support
[email protected]
Direct inquiry

Write to us

Newsletter

Receive product and research news by email.

Privacy policy
Eurolabs Peptides

Founded from research, built for research.

Research peptides from Eurolabs Peptides.

For research purposes only. Not for human consumption.

Peptides

  • Peptides
  • Science
  • Applications
  • Study journal
  • Favorites

Knowledge

  • Research Use Only
  • Study dossier
  • Inquiry list
  • Partners
  • Partner portal

Help

  • Payment & Shipping
  • FAQs
  • Contact
Language

Language

Accepted payments
SEPA
Bitcoin (BTC)
Litecoin (LTC)
Monero (XMR)
Solana (SOL)
Tether (USDT)
Shipping partner
DHL Shipping

© 2026 Euro Lab GbR. All rights reserved.

Site map·Legal notice·Privacy Policy·Terms & Conditions
Log in
  1. Home
  2. Peptides
  3. Growth Hormone Peptides
  4. Ipamorelin

EL-26· Research peptide

Ipamorelin

Batch analytics · >99 % purity

Growth hormone≥99% purityBatch analytics

Ipamorelin is a synthetic pentapeptide that stimulates growth hormone release through the GHRP and ghrelin receptor pathway. Animal studies showed a selective profile compared with GHRP-2 and GHRP-6.

Illustrative image; appearance and packaging may vary. 10 unlabelled vials, labelled only on the kit packaging. The selected strength applies.

Customer Reviews

No reviews yet. Be the first to share your experience.

Research Use Only (RUO)

HPLC analysisBatch-specific analytics
Independently verified quality
  • T.01
    Avg. 99.41% HPLC (2026)
    Every batch independently analyzed
  • T.02
    14-day money back
    On purity deviation
  • T.03
    GMP-compliant production
    ISO-certified lab partners
  • T.04
    Discreet ordering
    Neutral packaging
Quality assurance

Three independent verification layers

  • Synthesis QC labQ.01
    Q.01

    Tier I · Synthesis QC

    Tier I · Synthesis QC

    In-house · per step

    RP-HPLC, MS confirmation, sequence verification in cleanroom.

  • In-process analyticsQ.02
    Q.02

    Tier II · In-process

    Tier II · In-process

    Batch · final

    Identity, purity, and assay before release.

  • Third-party lab analyticsQ.03
    Q.03

    Tier III · Third-party lab

    Tier III · Third-party lab

    External · independent

    HPLC, ICP-MS, and microbiology by accredited lab.

953

satisfied

99.41%

Avg. purity 2026

4.8 ★

Store rating

EL-26 · Reference data

Selektiver GHS-R1a-Agonist (Pentapeptid)

Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Molecular weight
711.86 Da
CAS
170851-70-4
Origin
Synthese · Basel (CH)
Application fields
A.03

Aliases: NN703

OverviewQualityFAQs

About Ipamorelin (Ipamorelin)

Ipamorelin: a pentapeptide with a selective profile

Ipamorelin is a synthetic pentapeptide made up of five amino acids and belongs to the growth hormone secretagogues. In the late 1990s it was described as the first selective GH secretagogue: in the experiments at the time, it stimulated the release of growth hormone (GH) without stimulating the other pituitary hormones to the same extent. This very question of selectivity is what keeps the molecule interesting today.

Its site of action is the GHRP and ghrelin receptor pathway. Ipamorelin belongs to the ghrelin mimetics and binds to the corresponding receptor on the somatotropic cells of the pituitary. There it sets a cellular signaling cascade in motion that ends in the secretion of GH. Because this pathway runs through a different receptor from the one GHRH uses, its profile differs from that of a GHRH analog.

Selectivity: growth hormone in focus

GH release is part of a coordinated regulatory loop: GHRH drives it, somatostatin restrains it, and the ghrelin pathway provides its own input. A secretagogue that primarily uses this third pathway makes the somatotropic axis accessible in a targeted way.

In the original studies, Ipamorelin was tested on rat pituitary cells, in rats and in pigs. GH release was observed. The comparison with GHRP-2 and GHRP-6 was particularly informative: with Ipamorelin, the ACTH and cortisol response was lower than with the two reference peptides (original study by Raun and colleagues).

These findings come from cellular and animal models. They show how the peptide acts in these systems, and they are not evidence that cortisol or adverse effects remain unaffected in humans.

What has been measured in humans

In 1999, Ipamorelin was investigated in an early clinical study in healthy male volunteers. An acute episode of GH release was measured; at the same time, the compound's time course in the body could be described with a pharmacokinetic-pharmacodynamic model (study by Gobburu and colleagues). For research, this is a robust indication that the human GH axis responds to the peptide.

However, an acute hormone surge remains a biomarker. The study was small and limited to healthy men, as is usual for early clinical trials. The hormone level says nothing about muscle mass, body fat, sleep quality or recovery; that would require studies with precisely these endpoints.

Why bowel activity was investigated

Ghrelin and GH secretagogues do not affect only the pituitary. The receptor pathway is also involved in controlling gastrointestinal motility, and delayed bowel activity after abdominal surgery is a clinically relevant problem. This connection raised the question of whether a ghrelin mimetic could favorably influence postoperative ileus after bowel resection.

The phase II study and its primary result

In 2014, a multicenter, double-blind, placebo-controlled phase II study tested Ipamorelin in patients after bowel resection; 117 people were enrolled (phase II study by Beck and colleagues). Time to the first tolerated solid meal was numerically shorter with Ipamorelin, but the primary comparison did not reach statistical significance, with p = 0.15.

For this endpoint, the study therefore remains a negative finding: a trend without established efficacy. The intravenous study formulation and the surgical population are also important; the result cannot be transferred to ordinary digestive complaints.

Buy Ipamorelin: variants for research

Ipamorelin is available in variants with 5 mg and 10 mg per vial. Anyone who needs the peptide for their own research project can buy Ipamorelin and select the amount they need in the shop.

Quality, purity & batch documentation

Every batch is analyzed by an independent laboratory via HPLC before shipment. We document purity (avg. 99.41% in 2026), mass spectrometry identity, and sterility. Production follows GMP standards in ISO-certified laboratories.

Frequently asked questions

Ipamorelin is a synthetic pentapeptide made up of five amino acids. It belongs to the growth hormone secretagogues and stimulates GH release through the GHRP and ghrelin receptor pathway.

In comparative studies in pigs, Ipamorelin stimulated GH release while the ACTH and cortisol response was lower than with the two reference peptides. This selectivity has been shown in animal models and cannot be readily transferred to humans.

In an early clinical study with healthy male volunteers, acute GH release was measured and the compound's time course in the body was modeled. Whether this leads to benefits for body composition, sleep or recovery remains unresolved.

Because the ghrelin receptor pathway also influences bowel motility. The phase II study in patients after bowel resection showed a numerically shorter time to the first tolerated meal, but no statistically significant difference from placebo.

Ipamorelin is available in variants with 5 mg and 10 mg per vial.

Ready to ship
Strength per vial · Kit prices

1 Kit contains 10 vials

Total€179.001 Kit · 10 vials€17.90 / vial
1
SEPA
Bitcoin (BTC)
Litecoin (LTC)
Monero (XMR)
Solana (SOL)
Tether (USDT)

You May Also Like

CJC-1295 (Mod GRF 1-29)

CJC-1295 (Mod GRF 1-29)

Growth hormoneRecoveryAgeing research≥99% purityBatch analytics
€269.00
CJC-1295 No DAC + Ipamorelin

CJC-1295 No DAC + Ipamorelin

Growth hormone≥99% purityBatch analytics
€429.00
CJC-1295 with DAC

CJC-1295 with DAC

Growth hormone
€599.00
Sermorelin Acetate

Sermorelin Acetate

Growth hormone≥99% purityBatch analytics
€249.00
Tesamorelin

Tesamorelin

Weight managementGrowth hormoneAgeing research≥99% purityBatch analytics
€319.00
5-Amino-1MQ

5-Amino-1MQ

Weight management≥99% purityBatch analytics
€79.00
AHK-Cu

AHK-Cu

Skin≥99% purityBatch analytics
€109.00
AOD-9604

AOD-9604

Weight management
€239.00